Abstract:Objective: To study the expression of α5β1 integrin and phosphorylated ERK1/2(p-ERK1/2) in non-small cell lung cancer (NSCLC), and the effect of α5β1 integrin and ERK signal transduction pathway on proliferation and migration of A549 cells. Method: The expression of α5β1 integrin and p-ERK1/2 in 41 specimens of NSCLC, and 15 controled specimens were determined by immunohistochemical assay and Western blot analysis. The correlation between the results of two methods was then analyzed. A549 cells were cultured in vitro, with anti-α5β1 and ERK. inhibitor PD98059 as the tool drugs. The proliferation and apoptosis of the A549 cells were measured with the MTT assay and Annexin-V FITC PI double staining, respectively. The protein expression level of MMP-9 was measured with Western blot analysis. The protein expression levels of ERK1/2 were detected by Western blot analysis and the expression levels of ERK1/2 mRNA was measured by RT-PCR. Result: The expression of α5β1 integrin and p-ERK1/2 was significantly higher in NSCLC (58.53% and 65.52%, respectively) compared with that in the normal lung tissue (26.67% and 20.00% respectively). There was also a positive correlation of α5β1 integrin and p-ERK1/2 expression with pathological characteristics (P = 0.000, P = 0.030), lymph node metastasis (P = 0.014, P = 0.000), and clinical stage (P = 0.027, P = 0.038). The expression of α5β1 integrin was positively correlated with p-ERK1/2 expression (r = 0.375, P < 0.05). The anti-α5β1 and ERK inhibitor PD98059 could inhibit the proliferation of A549 cells, resulting in an increase of the percentage in the early apoptotic cells, and down-regulated the expression of MMP-9. In addition, the anti-α5β1 could inhibit the phosphorylated ratio of ERK by down-regulating the expression of ERK mRNA and the relative proteins. Conclusion: The positive rates of α5β1 integrin and p-ERK1/2 are higher in NSCLC than in the normal lung tissue. Anti-α5β1 can down-regulate the expression of ERK mRNA and the phosphorylated ratio, and can inhibit the proliferation of A549 cells and down-regulate the expression of MMP-9. This indicates that the α5β1 integrin-mediated ERK signal transduction pathway might lead to the abnormal proliferation and migration of A549 cells.

The role and clinical significance of αB-Crystallin in the proliferation and migration of non-small cell lung cancer

Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma

0052 Site-specific Relapse Pattern of the Triple Negative Tumors in Chinese Breast Cancer Patients

Expression and Prognostic Significance of the Alpha B-Crystallin Gene in Human Hepatocellular Carcinoma

Expression and clinical significance of Bcl-2 in non-small cell lung carcinoma

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

CRYAB Inhibits Migration and Invasion of Bladder Cancer Cells Through the PI3K/AKT and ERK Pathways.

Effect of α5β1 Integrin and ERK Signaling Pathway on Non-small Cell Lung Cancer

The Effects and Mechanisms of SLC34A2 in Tumorigenesis and Progression of Human Non-Small Cell Lung Cancer

Role of BAG2 gene in A549 cell proliferation and its clinical implications

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

The Small Heat Shock Protein Αa-Crystallin Negatively Regulates Pancreatic Tumorigenesis

The study of secretory clusterin on the biological behaviors of non-small cell lung cancer cells

Expression of XIAP Mrna and Survivin Mrna in Non-Small Cell Lung Cancer and Their Clinical Significance

Expression and significance of G-CSFR in non-small cell lung cancer

The expression of α-tubulin and clinical significance in NSCLC

SLC12A8 promotes the migration and invasion of non-small cell lung cancer (NSCLC) cells

Expression of AEG-1-1 gene in NSCLC and its clinical significance

Expression of Beclin-1 in non-small cell lung cancer and its clinical significance

Expression and clinical significance of bFGF and CCL 18 in non-small cell lung cancer

The role of ATP8A1 in non-small cell lung cancer